 | • レポートコード：MRC2012B1591 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、潰瘍性大腸炎治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。潰瘍性大腸炎治療の種類別市場規模（抗炎症薬、免疫系サプレッサー、その他）、用途別市場規模（病院、クリニック、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Johnson & Johnson、Sanofi、Novartis、MSD、Roche、AbbVie、AstraZeneca、GSK、Bayer、InDeX Pharmaceuticals、Eli Lilly and Company、Ferring Pharmaceuticals、Amgen、Takeda Pharmaceuticals Company、 ・地域別グローバル市場分析 2015年-2020年 ・潰瘍性大腸炎治療の北米市場（アメリカ、カナダ、メキシコ） ・潰瘍性大腸炎治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・潰瘍性大腸炎治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・潰瘍性大腸炎治療の南米市場（ブラジル、アルゼンチン） ・潰瘍性大腸炎治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗炎症薬、免疫系サプレッサー、その他 ・用途別分析：病院、クリニック、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Ulcerative Colitis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Ulcerative Colitis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Ulcerative Colitis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ulcerative Colitis Treatment market has been segmented into:
Anti-inflammatory Drugs
Immune System Suppressors
Other medications
By Application, Ulcerative Colitis Treatment has been segmented into:
Hospital
Clinic
Drugs Store
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ulcerative Colitis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Ulcerative Colitis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ulcerative Colitis Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Ulcerative Colitis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Ulcerative Colitis Treatment Market Share Analysis
Ulcerative Colitis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ulcerative Colitis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ulcerative Colitis Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Ulcerative Colitis Treatment are:
Pfizer
Johnson & Johnson
Sanofi
Novartis
MSD
Roche
AbbVie
AstraZeneca
GSK
Bayer
InDeX Pharmaceuticals
Eli Lilly and Company
Ferring Pharmaceuticals
Amgen
Takeda Pharmaceuticals Company
Table of Contents
1 Ulcerative Colitis Treatment Market Overview
1.1 Product Overview and Scope of Ulcerative Colitis Treatment
1.2 Classification of Ulcerative Colitis Treatment by Type
1.2.1 Global Ulcerative Colitis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Ulcerative Colitis Treatment Revenue Market Share by Type in 2019
1.2.3 Anti-inflammatory Drugs
1.2.4 Immune System Suppressors
1.2.5 Other medications
1.3 Global Ulcerative Colitis Treatment Market by Application
1.3.1 Overview: Global Ulcerative Colitis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugs Store
1.3.5 Others
1.4 Global Ulcerative Colitis Treatment Market by Regions
1.4.1 Global Ulcerative Colitis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Ulcerative Colitis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Ulcerative Colitis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Ulcerative Colitis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ulcerative Colitis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Ulcerative Colitis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ulcerative Colitis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 MSD
2.5.1 MSD Details
2.5.2 MSD Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 MSD SWOT Analysis
2.5.4 MSD Product and Services
2.5.5 MSD Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AbbVie SWOT Analysis
2.7.4 AbbVie Product and Services
2.7.5 AbbVie Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GSK SWOT Analysis
2.9.4 GSK Product and Services
2.9.5 GSK Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 InDeX Pharmaceuticals
2.11.1 InDeX Pharmaceuticals Details
2.11.2 InDeX Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 InDeX Pharmaceuticals SWOT Analysis
2.11.4 InDeX Pharmaceuticals Product and Services
2.11.5 InDeX Pharmaceuticals Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Eli Lilly and Company
2.12.1 Eli Lilly and Company Details
2.12.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Eli Lilly and Company SWOT Analysis
2.12.4 Eli Lilly and Company Product and Services
2.12.5 Eli Lilly and Company Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ferring Pharmaceuticals
2.13.1 Ferring Pharmaceuticals Details
2.13.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ferring Pharmaceuticals SWOT Analysis
2.13.4 Ferring Pharmaceuticals Product and Services
2.13.5 Ferring Pharmaceuticals Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Amgen
2.14.1 Amgen Details
2.14.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Amgen SWOT Analysis
2.14.4 Amgen Product and Services
2.14.5 Amgen Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Takeda Pharmaceuticals Company
2.15.1 Takeda Pharmaceuticals Company Details
2.15.2 Takeda Pharmaceuticals Company Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Takeda Pharmaceuticals Company SWOT Analysis
2.15.4 Takeda Pharmaceuticals Company Product and Services
2.15.5 Takeda Pharmaceuticals Company Ulcerative Colitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Ulcerative Colitis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Ulcerative Colitis Treatment Players Market Share
3.2.2 Top 10 Ulcerative Colitis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Ulcerative Colitis Treatment Revenue and Market Share by Regions
4.2 North America Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
5 North America Ulcerative Colitis Treatment Revenue by Countries
5.1 North America Ulcerative Colitis Treatment Revenue by Countries (2015-2020)
5.2 USA Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Ulcerative Colitis Treatment Revenue by Countries
6.1 Europe Ulcerative Colitis Treatment Revenue by Countries (2015-2020)
6.2 Germany Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Ulcerative Colitis Treatment Revenue by Countries
7.1 Asia-Pacific Ulcerative Colitis Treatment Revenue by Countries (2015-2020)
7.2 China Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
8 South America Ulcerative Colitis Treatment Revenue by Countries
8.1 South America Ulcerative Colitis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Ulcerative Colitis Treatment by Countries
9.1 Middle East & Africa Ulcerative Colitis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Ulcerative Colitis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Ulcerative Colitis Treatment Market Forecast by Type (2019-2024)
10.3 Anti-inflammatory Drugs Revenue Growth Rate (2015-2025)
10.4 Immune System Suppressors Revenue Growth Rate (2015-2025)
10.5 Other medications Revenue Growth Rate (2015-2025)
11 Global Ulcerative Colitis Treatment Market Segment by Application
11.1 Global Ulcerative Colitis Treatment Revenue Market Share by Application (2015-2020)
11.2 Ulcerative Colitis Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Drugs Store Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Ulcerative Colitis Treatment Market Size Forecast (2021-2025)
12.1 Global Ulcerative Colitis Treatment Market Size Forecast (2021-2025)
12.2 Global Ulcerative Colitis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Ulcerative Colitis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ulcerative Colitis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ulcerative Colitis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Ulcerative Colitis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Ulcerative Colitis Treatment Major Business
Table 7. Pfizer Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Ulcerative Colitis Treatment Product and Solutions
Table 10. Pfizer Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Johnson & Johnson Corporate Information, Location and Competitors
Table 12. Johnson & Johnson Ulcerative Colitis Treatment Major Business
Table 13. Johnson & Johnson Ulcerative Colitis Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Johnson & Johnson SWOT Analysis
Table 15. Johnson & Johnson Ulcerative Colitis Treatment Product and Solutions
Table 16. Johnson & Johnson Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Corporate Information, Location and Competitors
Table 18. Sanofi Ulcerative Colitis Treatment Major Business
Table 19. Sanofi Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi SWOT Analysis
Table 21. Sanofi Ulcerative Colitis Treatment Product and Solutions
Table 22. Sanofi Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Ulcerative Colitis Treatment Major Business
Table 25. Novartis Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Ulcerative Colitis Treatment Product and Solutions
Table 28. Novartis Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. MSD Corporate Information, Location and Competitors
Table 30. MSD Ulcerative Colitis Treatment Major Business
Table 31. MSD Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 32. MSD SWOT Analysis
Table 33. MSD Ulcerative Colitis Treatment Product and Solutions
Table 34. MSD Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Corporate Information, Location and Competitors
Table 36. Roche Ulcerative Colitis Treatment Major Business
Table 37. Roche Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Roche SWOT Analysis
Table 39. Roche Ulcerative Colitis Treatment Product and Solutions
Table 40. Roche Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. AbbVie Corporate Information, Location and Competitors
Table 42. AbbVie Ulcerative Colitis Treatment Major Business
Table 43. AbbVie Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 44. AbbVie SWOT Analysis
Table 45. AbbVie Ulcerative Colitis Treatment Product and Solutions
Table 46. AbbVie Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AstraZeneca Corporate Information, Location and Competitors
Table 48. AstraZeneca Ulcerative Colitis Treatment Major Business
Table 49. AstraZeneca Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 50. AstraZeneca SWOT Analysis
Table 51. AstraZeneca Ulcerative Colitis Treatment Product and Solutions
Table 52. AstraZeneca Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GSK Corporate Information, Location and Competitors
Table 54. GSK Ulcerative Colitis Treatment Major Business
Table 55. GSK Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 56. GSK SWOT Analysis
Table 57. GSK Ulcerative Colitis Treatment Product and Solutions
Table 58. GSK Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bayer Corporate Information, Location and Competitors
Table 60. Bayer Ulcerative Colitis Treatment Major Business
Table 61. Bayer Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Bayer SWOT Analysis
Table 63. Bayer Ulcerative Colitis Treatment Product and Solutions
Table 64. Bayer Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. InDeX Pharmaceuticals Corporate Information, Location and Competitors
Table 66. InDeX Pharmaceuticals Ulcerative Colitis Treatment Major Business
Table 67. InDeX Pharmaceuticals Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 68. InDeX Pharmaceuticals SWOT Analysis
Table 69. InDeX Pharmaceuticals Ulcerative Colitis Treatment Product and Solutions
Table 70. InDeX Pharmaceuticals Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Eli Lilly and Company Corporate Information, Location and Competitors
Table 72. Eli Lilly and Company Ulcerative Colitis Treatment Major Business
Table 73. Eli Lilly and Company Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Eli Lilly and Company SWOT Analysis
Table 75. Eli Lilly and Company Ulcerative Colitis Treatment Product and Solutions
Table 76. Eli Lilly and Company Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Ferring Pharmaceuticals Corporate Information, Location and Competitors
Table 78. Ferring Pharmaceuticals Ulcerative Colitis Treatment Major Business
Table 79. Ferring Pharmaceuticals Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Ferring Pharmaceuticals SWOT Analysis
Table 81. Ferring Pharmaceuticals Ulcerative Colitis Treatment Product and Solutions
Table 82. Ferring Pharmaceuticals Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Amgen Corporate Information, Location and Competitors
Table 84. Amgen Ulcerative Colitis Treatment Major Business
Table 85. Amgen Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Amgen SWOT Analysis
Table 87. Amgen Ulcerative Colitis Treatment Product and Solutions
Table 88. Amgen Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Takeda Pharmaceuticals Company Corporate Information, Location and Competitors
Table 90. Takeda Pharmaceuticals Company Ulcerative Colitis Treatment Major Business
Table 91. Takeda Pharmaceuticals Company Ulcerative Colitis Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Takeda Pharmaceuticals Company SWOT Analysis
Table 93. Takeda Pharmaceuticals Company Ulcerative Colitis Treatment Product and Solutions
Table 94. Takeda Pharmaceuticals Company Ulcerative Colitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Ulcerative Colitis Treatment Revenue (Million USD) by Players (2015-2020)
Table 96. Global Ulcerative Colitis Treatment Revenue Share by Players (2015-2020)
Table 97. Global Ulcerative Colitis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Ulcerative Colitis Treatment Revenue Market Share by Regions (2015-2020)
Table 99. North America Ulcerative Colitis Treatment Revenue by Countries (2015-2020)
Table 100. North America Ulcerative Colitis Treatment Revenue Market Share by Countries (2015-2020)
Table 101. Europe Ulcerative Colitis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Ulcerative Colitis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Ulcerative Colitis Treatment Revenue by Countries (2015-2020)
Table 104. South America Ulcerative Colitis Treatment Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Ulcerative Colitis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Ulcerative Colitis Treatment Revenue Market Share by Countries (2015-2020)
Table 107. Global Ulcerative Colitis Treatment Revenue (Million USD) by Type (2015-2020)
Table 108. Global Ulcerative Colitis Treatment Revenue Share by Type (2015-2020)
Table 109. Global Ulcerative Colitis Treatment Revenue Forecast by Type (2021-2025)
Table 110. Global Ulcerative Colitis Treatment Revenue by Application (2015-2020)
Table 111. Global Ulcerative Colitis Treatment Revenue Share by Application (2015-2020)
Table 112. Global Ulcerative Colitis Treatment Revenue Forecast by Application (2021-2025)
Table 113. Global Ulcerative Colitis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Ulcerative Colitis Treatment Picture
Figure 2. Global Ulcerative Colitis Treatment Revenue Market Share by Type in 2019
Figure 3. Anti-inflammatory Drugs Picture
Figure 4. Immune System Suppressors Picture
Figure 5. Other medications Picture
Figure 6. Ulcerative Colitis Treatment Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Drugs Store Picture
Figure 10. Others Picture
Figure 11. Global Ulcerative Colitis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Ulcerative Colitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Ulcerative Colitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Ulcerative Colitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Ulcerative Colitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Ulcerative Colitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Ulcerative Colitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Ulcerative Colitis Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Ulcerative Colitis Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Ulcerative Colitis Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Ulcerative Colitis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Ulcerative Colitis Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Ulcerative Colitis Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Ulcerative Colitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Ulcerative Colitis Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Ulcerative Colitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Ulcerative Colitis Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Ulcerative Colitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Ulcerative Colitis Treatment Revenue Market Share by Countries in 2019
Figure 44. China Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Ulcerative Colitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Ulcerative Colitis Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Ulcerative Colitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Ulcerative Colitis Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Ulcerative Colitis Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Ulcerative Colitis Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Ulcerative Colitis Treatment Revenue Share by Type in 2019
Figure 61. Global Ulcerative Colitis Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Anti-inflammatory Drugs Revenue Growth Rate (2015-2020)
Figure 63. Global Immune System Suppressors Revenue Growth Rate (2015-2020)
Figure 64. Global Other medications Revenue Growth Rate (2015-2020)
Figure 65. Global Ulcerative Colitis Treatment Revenue Share by Application (2015-2020)
Figure 66. Global Ulcerative Colitis Treatment Revenue Share by Application in 2019
Figure 67. Global Ulcerative Colitis Treatment Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospital Revenue Growth Rate (2015-2020)
Figure 69. Global Clinic Revenue Growth Rate (2015-2020)
Figure 70. Global Drugs Store Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Ulcerative Colitis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Ulcerative Colitis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Ulcerative Colitis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Ulcerative Colitis Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
潰瘍性大腸炎の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Ulcerative Colitis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ulcerative Colitis market …- 潰瘍性大腸炎免疫治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ulcerative Colitis Immunology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ulcerativ…
- 潰瘍性大腸炎治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drug for Ulcerative Colitis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug for Ulcerati…
- 潰瘍性大腸炎免疫薬 の世界市場（～2026年） Market Analysis and Insights: Global Ulcerative Colitis Immunology Drugs Market The global Ulcerative Colitis Immunology Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ulcerative Colitis Immunology Drugs Scope a…
- 免疫介在性炎症性疾患治療の世界市場（～2026年） Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune respon…